Equity Method Investments (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Sep. 30, 2020 |
Jun. 30, 2020 |
Mar. 31, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Investments in unconsolidated affiliates | ||||||||||
| Equity in earnings of unconsolidated affiliate | $ 21,450 | $ 24,419 | $ 57,621 | $ (83,408) | ||||||
| Dividends from unconsolidated affiliates | (105,325) | (128,267) | ||||||||
| Impairment | (610,632) | |||||||||
| Balance Sheet | ||||||||||
| Current assets | 708,853 | 708,853 | $ 574,139 | |||||||
| Total assets | 13,471,538 | 13,349,739 | 13,471,538 | 13,349,739 | 13,150,845 | |||||
| Current liabilities | 2,802,682 | 2,802,682 | 983,054 | |||||||
| Total equity | 5,135,242 | $ 5,718,414 | $ 6,227,949 | 5,983,881 | $ 6,432,979 | $ 6,592,540 | 5,135,242 | 5,983,881 | 6,090,271 | $ 6,970,743 |
| Total liabilities and equity | 13,471,538 | 13,471,538 | 13,150,845 | |||||||
| Revenues | 534,422 | 380,591 | 2,227,988 | 2,182,607 | ||||||
| Operating expenses | 1,218,496 | 1,134,700 | 3,460,472 | 3,281,205 | ||||||
| Income (loss) from operations | (684,074) | (754,109) | (1,232,484) | (1,098,598) | ||||||
| Net loss including noncontrolling interests | $ (566,575) | $ (534,451) | (11,104) | $ (553,846) | $ (463,068) | $ (338,810) | $ (1,112,130) | (1,355,724) | ||
| Antero Midstream Corporation | ||||||||||
| Equity Method Investments | ||||||||||
| Ownership percentage | 29.10% | 29.10% | ||||||||
| Equity Method Investment, Nonconsolidated Investee or Group of Investees | Antero Midstream Corporation | ||||||||||
| Investments in unconsolidated affiliates | ||||||||||
| Balance at beginning of period | $ 255,082 | $ 255,082 | ||||||||
| Equity in earnings of unconsolidated affiliate | 57,621 | |||||||||
| Dividends from unconsolidated affiliates | (105,325) | |||||||||
| Elimination of intercompany profit | 29,219 | |||||||||
| Balance at end of period | $ 236,597 | 236,597 | ||||||||
| Fair value of investment | 1,400,000 | 1,400,000 | 1,100,000 | |||||||
| Balance Sheet | ||||||||||
| Current assets | 87,490 | 87,490 | 93,931 | |||||||
| Noncurrent assets | 5,446,143 | 5,446,143 | 5,516,981 | |||||||
| Total assets | 5,533,633 | 5,533,633 | 5,610,912 | |||||||
| Current liabilities | 118,690 | 118,690 | 94,005 | |||||||
| Noncurrent liabilities | 3,102,350 | 3,102,350 | 3,098,621 | |||||||
| Total equity | 2,312,593 | 2,312,593 | 2,418,286 | |||||||
| Total liabilities and equity | $ 5,533,633 | 5,533,633 | $ 5,610,912 | |||||||
| Revenues | 681,712 | 696,859 | ||||||||
| Operating expenses | 254,905 | 929,480 | ||||||||
| Income (loss) from operations | 426,807 | (232,621) | ||||||||
| Net loss including noncontrolling interests | $ 252,991 | $ (198,985) | ||||||||
| X | ||||||||||
- Definition Amount of intercompany profit eliminated for equity method investments. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Fair value portion of investments accounted under the equity method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of obligation due after one year or beyond the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|